BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 19596944)

  • 1. Impact of interstitial lung disease on survival for patients with non-small cell lung cancer.
    Miyazaki K; Satoh H; Kurishima K; Nakamura R; Ishikawa H; Kagohashi K; Ohara G; Hizawa N
    Anticancer Res; 2009 Jul; 29(7):2671-4. PubMed ID: 19596944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleural effusion as a significant prognostic factor in non-small cell lung cancer.
    Naito T; Satoh H; Ishikawa H; Yamashita YT; Kamma H; Takahashi H; Ohtsuka M; Hasegawa S
    Anticancer Res; 1997; 17(6D):4743-6. PubMed ID: 9494600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of interstitial lung disease on short-term and long-term survival of patients undergoing surgery for non-small-cell lung cancer: analysis of risk factors.
    Voltolini L; Bongiolatti S; Luzzi L; Bargagli E; Fossi A; Ghiribelli C; Rottoli P; Gotti G
    Eur J Cardiothorac Surg; 2013 Jan; 43(1):e17-23. PubMed ID: 23129356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of highly active antiretroviral therapy on survival of HIV infected patients with non-small-cell lung cancer.
    Lavolé A; Chouaïd C; Baudrin L; Wislez M; Raguin G; Pialoux G; Girard PM; Milleron B; Cadranel J
    Lung Cancer; 2009 Sep; 65(3):345-50. PubMed ID: 19135758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
    Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
    Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of preexisting interstitial lung disease in Japanese patients with small-cell lung cancer.
    Togashi Y; Masago K; Handa T; Tanizawa K; Okuda C; Sakamori Y; Nagai H; Kim YH; Mishima M
    Clin Lung Cancer; 2012 Jul; 13(4):304-11. PubMed ID: 22169479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term surgical outcome in patients with lung cancer and coexisting severe COPD.
    Nakajima T; Sekine Y; Yamada Y; Suzuki H; Yasufuku K; Yoshida S; Suzuki M; Shibuya K; Fujisawa T; Yoshino I
    Thorac Cardiovasc Surg; 2009 Sep; 57(6):339-42. PubMed ID: 19707975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial lung disease in patients with small cell lung cancer.
    Miyazaki K; Satoh H; Kurishima K; Nakamura R; Ishikawa H; Kagohashi K; Hizawa N
    Med Oncol; 2010 Sep; 27(3):763-7. PubMed ID: 19657749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of palliative procedures and clinical outcomes in patients with advanced non-small cell lung cancer.
    Kim HJ; Kim YJ; Seo MD; Yi HG; Lee SH; Lee SM; Kim DW; Yang SC; Lee CT; Lee JS; Kim YW; Heo DS
    Lung Cancer; 2009 Aug; 65(2):242-6. PubMed ID: 19147252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer.
    Miyoshi K; Moriyama S; Kunitomo T; Nawa S
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):429-34. PubMed ID: 19185165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three immunomarker support vector machines-based prognostic classifiers for stage IB non-small-cell lung cancer.
    Zhu ZH; Sun BY; Ma Y; Shao JY; Long H; Zhang X; Fu JH; Zhang LJ; Su XD; Wu QL; Ling P; Chen M; Xie ZM; Hu Y; Rong TH
    J Clin Oncol; 2009 Mar; 27(7):1091-9. PubMed ID: 19188679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of HLA class I alleles on postoperative prognosis of lung cancer patients in Japan.
    Nagata Y; Hanagiri T; Mizukami M; Kuroda K; Shigematsu Y; Baba T; Ichiki Y; Yasuda M; So T; Takenoyama M; Sugio K; Nagashima A; Yasumoto K
    Lung Cancer; 2009 Jul; 65(1):91-7. PubMed ID: 19054590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy and prognostic impact of a vessel invasion grading system for stage IA non-small cell lung cancer.
    Hashizume S; Nagayasu T; Hayashi T; Hidaka S; Tsuchiya T; Tagawa T; Yamasaki N; Furukawa K; Matsumoto K; Miyazaki T
    Lung Cancer; 2009 Sep; 65(3):363-70. PubMed ID: 19157635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survival.
    Steger V; Walles T; Kosan B; Walker T; Kyriss T; Veit S; Dippon J; Friedel G
    Ann Thorac Surg; 2009 Jun; 87(6):1676-83. PubMed ID: 19463576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of age on survival of clinical stage I non-small-cell lung cancer.
    Sigel K; Bonomi M; Packer S; Wisnivesky J
    Ann Surg Oncol; 2009 Jul; 16(7):1912-7. PubMed ID: 19408051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
    Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative leukocytosis, anemia and thrombocytosis are associated with poor survival in non-small cell lung cancer.
    Tomita M; Shimizu T; Hara M; Ayabe T; Onitsuka T
    Anticancer Res; 2009 Jul; 29(7):2687-90. PubMed ID: 19596947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of sleeve lobectomy in the management of non-small cell lung carcinoma and low-grade neoplasms.
    Merritt RE; Mathisen DJ; Wain JC; Gaissert HA; Donahue D; Lanuti M; Allan JS; Morse CR; Wright CD
    Ann Thorac Surg; 2009 Nov; 88(5):1574-81; discussion 1581-2. PubMed ID: 19853115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of prognostic significance of serum DNA methylation of DAPK, MGMT, and GSTPI in patients with non-small cell lung cancer.
    Hoffmann AC; Kaifi JT; Vallböhmer D; Yekebas E; Grimminger P; Leers JM; Izbicki JR; Hölscher AH; Schneider PM; Metzger R; Brabender J
    J Surg Oncol; 2009 Oct; 100(5):414-7. PubMed ID: 19653236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchodilatation test response predictors in lung function assessment of patients with resectable lung cancer and concomitant chronic obstructive pulmonary disease.
    Zarić B; Stanić J; Milovancev A; Canak V; Andjelić B; Sarcev T; Kojicić M
    J BUON; 2006; 11(2):185-90. PubMed ID: 17318969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.